Streetbeat News

Products Services

GLW

LUMN

OCFS

TINT

Corning Incorporated (NYSE:GLW) shares rise as the company updates its 'Springboard' plan, aiming for $3 billion in additional sales and a 20% operating margin by 2026. The plan includes price hikes and AI product launches, boosting its Optical Communications division. Corning's products support Lumen Technologies' network expansion. Investors can access Corning through ETFs like ProShares Smart Materials ETF (NYSE:TINT) and Professionally Managed Portfolios Otter Creek Focus Strategy ETF (NYSE:OCFS).

Portfolio Pulse from Lekha Gupta

September 19, 2024 | 4:26 pm

ELAN

Elanco Animal Health has received FDA approval for Zenrelia, a new treatment for pruritus and atopic dermatitis in dogs. This approval could enhance Elanco's product portfolio and potentially boost its market position in the animal health sector.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 4:26 pm

ICUI

ICU Medical's subsidiary, Smiths Medical, has recalled certain Bivona tracheostomy tubes due to manufacturing defects that could cause severe injury or death. The FDA classified this as a serious recall, with 35 reported injuries and two deaths. ICUI stock was up 2.25% following the news.

Portfolio Pulse from Vandana Singh

September 19, 2024 | 4:20 pm

RHHBY

Roche's phase 3 CENTERSTONE study shows that Xofluza, an antiviral drug, significantly reduces the transmission of influenza viruses. The study met its primary endpoint, indicating a single dose can prevent household transmission. This adds to Xofluza's benefits, which is already approved for treating and preventing influenza. The study was partially funded by US federal agencies.

Portfolio Pulse from Vandana Singh

September 19, 2024 | 4:13 pm

BEN

IVZ

Peter Mallouk, CEO of Creative Planning, warns of a potential market correction and digital disruption in the RIA industry, despite its projected growth. He highlights risks from deficit spending and technological advancements like AI. Franklin Templeton and Invesco show strong performance, but may be vulnerable if market conditions change.

Portfolio Pulse from Stjepan Kalinic

September 19, 2024 | 4:10 pm

ACHL

Achilles Therapeutics shares surged after announcing a strategic shift to discontinue its TIL-based cNeT program and explore collaborations for cancer treatment. The company is considering partnerships and potential mergers or acquisitions, with BofA Securities as a financial advisor. Cost-cutting measures, including workforce reduction, are also being implemented.

Portfolio Pulse from Vaishali Prayag

September 19, 2024 | 4:07 pm

ALB

LAAC

LAC

SQM

Lithium stocks are experiencing a rise in share prices following an increase in lithium prices, which was triggered by the Federal Reserve's decision to cut rates by 50 basis points.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 4:04 pm

ACAD

Acadia Pharmaceuticals has entered into a Master Service Agreement with Axcelead Drug Discovery Partners to enhance drug discovery projects, particularly in neuroscience. The agreement aims to leverage Axcelead's expertise to support Acadia's goal of developing innovative medicines. Financial terms were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 4:04 pm

QURE

uniQure Biopharma has been granted Orphan Drug Designation by the FDA for its gene therapy targeting Fabry disease. This designation is for their adeno-associated viral vector serotype 5 encoding human alpha-galactosidase A.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 3:54 pm

UPST

Upstart Holdings, Inc. (NASDAQ:UPST) shares are trading higher following a 50 basis point interest rate cut by the Federal Reserve. This cut could benefit Upstart's loan segments by attracting more borrowers. Additionally, Upstart announced an upsized private offering of $375 million in convertible senior notes. Despite the current rally, analysts have mixed ratings on UPST, with an average price target suggesting potential downside.

Portfolio Pulse from Erica Kollmann

September 19, 2024 | 3:53 pm